Cargando…

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients

The underlying mechanisms of ovarian cancer (OvCa) dissemination are still poorly understood, and novel molecular markers for this cancer type are urgently needed. In search of adhesion molecules with prognostic relevance in OvCa, we compared tumors with good outcome (alive > 3 years) and those w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira-Ferrer, Leticia, Goswami, Roshni, Galatenko, Vladimir, Ding, Yi, Eylmann, Kathrin, Legler, Karen, Kürti, Sascha, Schmalfeldt, Barbara, Milde-Langosch, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046165/ https://www.ncbi.nlm.nih.gov/pubmed/30050594 http://dx.doi.org/10.1155/2018/6714287

Ejemplares similares

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation
por: Hamester, Fabienne, et al.
Publicado: (2019)

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients
por: Kuerti, Sascha, et al.
Publicado: (2017)

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
por: Legler, Karen, et al.
Publicado: (2018)

Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer
por: Volk, Annabelle, et al.
Publicado: (2023)

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
por: Ding, Yi, et al.
Publicado: (2022)

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2020)

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
por: Trillsch, Fabian, et al.
Publicado: (2016)

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
por: Reimer, Francesca, et al.
Publicado: (2023)

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
por: Hamester, Fabienne, et al.
Publicado: (2022)

Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer
por: Prieske, Katharina, et al.
Publicado: (2017)

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
por: Kempska, Joanna, et al.
Publicado: (2023)

Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
por: Ding, Yi, et al.
Publicado: (2021)

Ovarian Cancer-Cell Pericellular Hyaluronan Deposition Negatively Impacts Prognosis of Ovarian Cancer Patients
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2022)

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
por: Eichelser, Corinna, et al.
Publicado: (2014)

TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
por: Mahner, Sven, et al.
Publicado: (2010)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis
por: Zhang, Hui, et al.
Publicado: (2013)

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008)

Transcriptome Analysis in Vulvar Squamous Cell Cancer
por: Prieske, Katharina, et al.
Publicado: (2021)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

c-FOS suppresses ovarian cancer progression by changing adhesion
por: Oliveira-Ferrer, L, et al.
Publicado: (2014)

CEACAMs: their role in physiology and pathophysiology
por: Kuespert, Katharina, et al.
Publicado: (2006)

Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses
por: Singer, Bernhard B., et al.
Publicado: (2014)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

CEACAM1 Negatively Regulates IL-1β Production in LPS Activated Neutrophils by Recruiting SHP-1 to a SYK-TLR4-CEACAM1 Complex
por: Lu, Rongze, et al.
Publicado: (2012)

Heterogeneity of CEACAM5 in breast cancer
por: Bechmann, Marc B., et al.
Publicado: (2020)

Interactions of pathogenic Escherichia coli with CEACAMs
por: Sheikh, Alaullah, et al.
Publicado: (2023)

CEACAM expression in an in-vitro prostatitis model
por: Kube-Golovin, Irina, et al.
Publicado: (2023)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src
por: Müller, Mario M., et al.
Publicado: (2009)

Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
por: Klaile, Esther, et al.
Publicado: (2017)

Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier
por: Hamester, Fabienne, et al.
Publicado: (2022)

Reversal of obesity development in Ceacam1 ( −/− ) male mice by bone marrow transplantation or introduction of the human CEACAM1 gene
por: Zhang, Zhifang, et al.
Publicado: (2022)

CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
por: Kurlinkus, Benediktas, et al.
Publicado: (2021)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

CEACAM1: Expression and Role in Melanocyte Transformation
por: Turcu, Gabriela, et al.
Publicado: (2016)

CEACAM1-Mediated Inhibition of Virus Production
por: Vitenshtein, Alon, et al.
Publicado: (2016)

CEACAM1 promotes vascular aging processes
por: Kleefeldt, Florian, et al.
Publicado: (2020)

Structural analysis of human CEACAM1 oligomerization
por: Gandhi, Amit K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hkkp4e24q61lcvgqmsu2qjfloe